Dr Agarwal’s Health Care IPO: Check Allotment Status, GMP, Subscription Details and More

Dr Agarwal’s Health Care IPO received a moderate response from the investors. The issue was subscribed just over 1.55 times. By the final day of bidding, the Rs 3,027 crore issue was subscribed by qualified institutional buyers (QIBs) at 4.64 times, retail investors at 0.41 times, and non-institutional investors (NIIs) at 0.40 times. According to NSE data, Dr Agarwal's IPO was subscribed 1.55 times on the third day.

The allotment of the shares for the issue is expected to be finalised later today. Investors can check their allotment status on the official websites of the BSE, NSE or KFin Tech, the issue's registrar. The shares are expected to be listed on the BSE and NSE on Wednesday, February 5.

Follow the steps below to check Dr Agarwal’s Health Care IPO allotment on BSE:

• Visit the official BSE allotment page via this link: [https://www.bseindia.com/investors/appli_check.aspx]

• Under the "Issue Type" section, choose "equity"

• From the dropdown menu, select "Dr Agarwal’s Health IPO"

• Enter your PAN number or application number

• Click on the "submit" button to view your allotment status

How to check allotment status on the Kfin Technologies website:

• Open the Kfin Technologies website on any smart device

• You can check status by using one of five different links

• After selecting one of the five URLs, choose "Dr Agarwal IPO" from the "Select IPO" dropdown menu

• Enter your PAN, Demat account number or application number

• Enter the captcha code and click “Submit”

Dr Agarwal Health Care IPO GMP

Dr Agarwal's Health IPO was commanding a grey market premium (GMP) of Rs 0.5, as of February 3, 2025, 08:06 AM. With the price band set at Rs 402, the estimated listing price for the IPO is Rs 402.5. This suggests an expected gain of 0.12% per share on the listing day.

Dr Agarwal’s Health Care IPO Objective

The company aims to use the proceeds from the issue to repay/prepay certain borrowings in part or full, for general corporate purposes and unidentified inorganic acquisitions.

About the company

Incorporated in April 2010, Chennai-based Dr Agarwal’s Health Care Limited is a prominent healthcare company focused on advanced eye care services. The company’s flagship brand, Dr Agarwal’s Eye Institute, operates through a network of domestic and international subsidiaries, including Dr Agarwal’s Eye Hospital Limited and Aditya Jyot Eye Hospital Private Limited, with operations in countries like Ghana, Kenya, Mozambique, and Madagascar.

The company provides a wide range of eye care services, including routine eye check-ups, cataract surgeries, LASIK procedures, retina treatments, and corneal transplants. With cutting-edge technologies like robotics and advanced imaging, Dr Agarwal’s Health Care Limited offers precise, effective treatments, maintaining high clinical standards and exceptional patient care.